These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25861656)

  • 21. An HIV vaccine: how and when?
    Esparza J
    Bull World Health Organ; 2001; 79(12):1133-7. PubMed ID: 11799445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerating HIV-1 Vaccine Efficacy Trials.
    Barouch DH; Michael NL
    Cell; 2014 Nov; 159(5):969-972. PubMed ID: 25416935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innovative approaches to develop prophylactic and therapeutic vaccines against HIV/AIDS.
    Cafaro A; Macchia I; Maggiorella MT; Titti F; Ensoli B
    Adv Exp Med Biol; 2009; 655():189-242. PubMed ID: 20047043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of vaccine research and development: the human immunodeficiency virus (HIV).
    Girard MP; Osmanov SK; Kieny MP
    Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thirty years of HIV and AIDS: future challenges and opportunities.
    Dieffenbach CW; Fauci AS
    Ann Intern Med; 2011 Jun; 154(11):766-71. PubMed ID: 21628350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accelerating the development of an AIDS vaccine: the AIDS vaccine for Asia Network (Avan).
    Pitisuttithum P; Rerks-Ngarm S; Chiu J; Kim J; Benenson M; Kent SJ; Tamashiro H; Manrique A; Bernstein A; Goyal R; Ditangco RA; Cooper DA; Osmanov S; Mathieson B; Sandstrom E; Esparza J; Hoff R; Shao Y;
    Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1130-46. PubMed ID: 22299439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV: epidemiology and strategies for therapy and vaccination.
    Marcus U; Dittmar MT; Kräusslich HG
    Intervirology; 2002; 45(4-6):260-6. PubMed ID: 12566708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conditional live virus as a novel approach towards a safe live attenuated HIV vaccine.
    Das AT; Zhou X; Vink M; Klaver B; Berkhout B
    Expert Rev Vaccines; 2002 Oct; 1(3):293-301. PubMed ID: 12901570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonstructural HIV proteins as targets for prophylactic or therapeutic vaccines.
    Ferrantelli F; Cafaro A; Ensoli B
    Curr Opin Biotechnol; 2004 Dec; 15(6):543-56. PubMed ID: 15560981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV vaccine development: challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem.
    Koff WC
    Vaccine; 2012 Jun; 30(29):4310-5. PubMed ID: 22100891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Closing the door to human immunodeficiency virus.
    Kang Y; Guo J; Chen Z
    Protein Cell; 2013 Feb; 4(2):86-102. PubMed ID: 23479426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of prophylactic AIDS vaccines: the current state of affairs.
    Hanke T
    Curr Opin Mol Ther; 2003 Feb; 5(1):25-32. PubMed ID: 12669467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A safe, effective and affordable HIV vaccine--an urgent global need.
    Joseph J; Etcheverry F; Alcami J; María GJ
    AIDS Rev; 2005; 7(3):131-8. PubMed ID: 16302460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AIDS vaccine development: perspectives, challenges & hopes.
    Excler JL
    Indian J Med Res; 2005 Apr; 121(4):568-81. PubMed ID: 15817964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV vaccines: new frontiers in vaccine development.
    Duerr A; Wasserheit JN; Corey L
    Clin Infect Dis; 2006 Aug; 43(4):500-11. PubMed ID: 16838241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The RV144 Thai HIV vaccine trial.
    Plotkin SA
    Hum Vaccin; 2010 Feb; 6(2):159. PubMed ID: 20431337
    [No Abstract]   [Full Text] [Related]  

  • 37. Predictive value of primate models for AIDS.
    Haigwood NL
    AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 Tat-based vaccines: an overview and perspectives in the field of HIV/AIDS vaccine development.
    Caputo A; Gavioli R; Bellino S; Longo O; Tripiciano A; Francavilla V; Sgadari C; Paniccia G; Titti F; Cafaro A; Ferrantelli F; Monini P; Ensoli F; Ensoli B
    Int Rev Immunol; 2009; 28(5):285-334. PubMed ID: 19811313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent progress in HIV vaccines inducing mucosal immune responses.
    Pavot V; Rochereau N; Lawrence P; Girard MP; Genin C; Verrier B; Paul S
    AIDS; 2014 Jul; 28(12):1701-18. PubMed ID: 25009956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanding research capacity and accelerating AIDS vaccine development in Asia.
    Excler JL; Pitisuttithum P; Rerks-Ngarm S; Shao Y; Zhang L; Tamashiro H; Osmanov S;
    Southeast Asian J Trop Med Public Health; 2008 Jul; 39(4):766-84. PubMed ID: 19058617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.